CrushSCI.com
51.0平均天数
45.5中位天数
14最短天数
130最长天数
1612025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

66 天

Integrative Analysis of Cuproptosis-Related Genes and Repurposable Therapeutic Agents in Type A Aortic Dissection

作者
Chengbin Tang; Yi Dai; Tao Chen; Jun Shao; Tao Zhu; Jingting Ye; Yusheng Shu展开收起
作者单位
1. Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou, China; 2. Department of Center for Cardiac Macrovascular Disease, Northern Jiangsu People’s Hospital, Yangzhou, China; 3. Department of Thoracic Surgery, Northern Jiangsu People’s Hospital, Yangzhou, China展开收起
PDF源文件 DOI 网页
130 天

Salidroside Alleviates Atherosclerosis by Inhibiting Ferroptosis Through the RAG1/Keap1/Nrf2 Axis

作者
Xiangnan Song; Qing Yang; Jie Yang; Jiali Xu; Yingyu Xiang; Yanhong Liu; Hui Chi展开收起
作者单位
1. Clinical Laboratory Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; 2. Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China展开收起
PDF源文件 DOI 网页
17 天

Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories

作者
Teruhiko Imamura展开收起
作者单位
1. Second Department of Internal Medicine, University of Toyama, Toyama, Japan展开收起
PDF源文件 DOI 网页
37 天

Ivabradine Versus Digitalis Glycosides in Heart Failure With Reduced Ejection Fraction: A Comparative Appraisal of Two Additional Medical Therapies

作者
Vittorio Beltrani; Marco Bergonti; Martin R. Gruebler; Giordano M. Pugliesi; Luca Fazzini; Mattia Arrigo; Gregorio Tersalvi展开收起
作者单位
1. Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; 2. Department of Cardiology, Istituto Cardiocentro Ticino, Lugano, Switzerland; 3. Department of Internal Medicine, Ente Ospedaliero Cantonale, Mendrisio, Switzerland; 4. Department of Cardiology, University Hospital Wiener Neustadt, Danube Private University, Wiener Neustadt, Austria; 5. Department of Internal Medicine, Medical University of Graz, Graz, Austria; 6. Medical Faculty, Sigmund Freud University, Vienna, Austria; 7. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, USA; 8. Non-Invasive Cardiac Imaging Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; 9. Cardiovascular Department, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy; 10. Department of Internal Medicine, Ente Ospedaliero Cantonale, Lugano, Switzerland展开收起
PDF源文件 DOI 网页
17 天

Fixed-Dose Combination Versus Add-On Therapy: Clarifying the Role of Cilostazol–Rosuvastatin in Peripheral Artery Disease

作者
Dezheng Lu; Chunyan Kuang展开收起
作者单位
1. Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China; 2. Department of Cardiology, Guizhou Provincial People’s Hospital, Guiyang, China展开收起
PDF源文件 DOI 网页
62 天

Organelle Homeostasis and Metabolic Resilience: TFEB at the Crossroads of Lysosomal and Mitochondrial Adaptation

作者
Matthew J. Brody; Nageswara R. Madamanchi展开收起
作者单位
1. Department of Pharmacology, University of Michigan Medical School, Ann Arbor, USA; 2. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, USA展开收起
PDF源文件 DOI 网页

FAQ

CARDIOVASCULAR DRUGS AND THERAPY审稿要多久?

截至2026-11-19,CrushSCI 收录了 CARDIOVASCULAR DRUGS AND THERAPY 的 20 篇完整审稿记录。最快一篇从收稿到录用用了 14 天(Rethinking Plaque Stabilization with Evolocumab in Diabetes: Methodological Considerations from the YELLOW III Trial,2026-09-27 收稿,2026-10-11 录用),最慢一篇用了 130 天;平均 51.0 天,中位数 45.5 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。